Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10487086 Macrocycles as factor XIa inhibitors

Patent 10487086 was granted and assigned to Bristol-Myers Squibb on November, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Bristol-Myers Squibb

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

104870860

Patent Inventor Names

Donald J. P. Pinto0

Yoon Jeon0

Yufeng Wang0

Zilun Hu0

Carl P. Decicco0

James R. Corte0

Joanne M. Smallheer0

Karen A. Rossi0

...

Date of Patent

November 26, 2019

Patent Application Number

157184310

Date Filed

September 28, 2017

Patent Citations Received

‌

US Patent 12129265 Therapeutic agents and uses thereof

Patent Primary Examiner

‌

Noble E Jarrell

Patent abstract

The present invention provides compounds of Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10487086 Macrocycles as factor XIa inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API